| Lipomatous Neoplasm studied in …STUDIED_INderived155 of 155show fewer |
|---|
| → studied in | NCT06498648Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923778Phase 2 · active not recruiting Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686367Phase 2 · not yet recruiting Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06422806Phase 3 · recruiting Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694871Phase 2 · active not recruiting Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06025747Phase 1 · recruiting A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843967Phase 1/Phase 2 · recruiting A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Well-Differentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823491Phase 3 · not yet recruiting Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07802652Phase 2 · not yet recruiting Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03307616Phase 2 · active not recruiting Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04438824Phase 2 · active not recruiting Palbociclib and INCMGA00012 in People With Advanced Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04031677Phase 3 · recruiting Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797270NA · not yet recruiting Ultrasound-Guided Emulsification Therapy in the Clinical Treatment of Subcutaneous Lipomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389799Phase 2 · recruiting A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261657early Phase 1 · recruiting N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044768Phase 2 · active not recruiting Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06975293Phase 1/Phase 2 · recruiting STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04557449Phase 2 · active not recruiting Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06903208NA · recruiting RFA for Superficial Lipomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617572available Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04715191Phase 1 · recruiting Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741877Phase 2 · not yet recruiting A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07734805active not recruiting Radiological Diagnosis of Pediatric Neck Swellings · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06083883Phase 1 · recruiting Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07237425Phase 1 · recruiting Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07377747recruiting Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Retroperitoneal Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06414434Phase 1 · active not recruiting BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04668300Phase 2 · active not recruiting Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789172Phase 1 · recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02846987Phase 2 · active not recruiting Study of Abemaciclib in Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132922Phase 1 · active not recruiting MAGE-A4ᶜ¹º³²T for Multi-Tumor · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06957431Phase 1 · recruiting Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898365completed Study of Kidney Tumors in Younger Patients · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Angiolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05492682Phase 1 · recruiting START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820164Phase 1/Phase 2 · recruiting Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836571Phase 2 · active not recruiting Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361436Phase 1 · active not recruiting Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05103631Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441538NA · completed Optimizing the Timing for Facial Surgical Dressing Removal · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05218499Phase 2/Phase 3 · completed Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432932recruiting Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04794127Phase 2 · completed Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148050Phase 1 · recruiting Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07384299completed Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169344Phase 2 · recruiting Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173972Phase 2 · recruiting Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Pleomorphic Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04377932Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06058793Phase 3 · completed Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06849986Phase 2 · recruiting IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Pleomorphic Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526679Phase 1/Phase 2 · completed Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05120271Phase 1/Phase 2 · active not recruiting BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496569Phase 2 · terminated TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224568Phase 1 · not yet recruiting Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06198296Phase 1 · recruiting Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05886634Phase 2 · active not recruiting A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01841047NA · completed Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899805Phase 2 · completed A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242238Phase 1 · completed Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299163Phase 1 · terminated NM32-2668 in Adult Patients With Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115681completed Real-world Study of Dedifferentiated Liposarcoma Patients in China · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05580588Phase 2 · terminated Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07014163NA · recruiting Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04785196Phase 1/Phase 2 · recruiting APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04213794early Phase 1 · terminated Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04224064NA · recruiting Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02249949Phase 2 · completed Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979442Phase 3 · terminated Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06748872Phase 1 · not yet recruiting EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06694324Phase 2 · not yet recruiting First-line Treatment of Advanced/unresectable DDLPS · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604783Phase 1 · terminated Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978859Phase 2 · completed Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06436846recruiting Genomic Risk in Retroperitoneal Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Retroperitoneal Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06419244NA · unknown Myosteatosis in Oeso-gastric Cancer: Clinical Impacts · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Lipomatous Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670069Phase 1 · terminated Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116683Phase 2 · terminated ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600649Phase 1 · unknown Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05905341Phase 1 · withdrawn Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048371Phase 2 · completed SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05094804Phase 1/Phase 2 · unknown A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03063632Phase 2 · completed Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02500797Phase 2 · completed Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03450122Phase 1 · completed Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06039046not yet recruiting Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266196Phase 1/Phase 2 · unknown A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399448Phase 1 · terminated NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02275286Phase 1/Phase 2 · recruiting Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02606461Phase 2/Phase 3 · completed Selinexor in Advanced Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959033terminated Patient Reported Outcome Measures (PROMs) With Trabectedin · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04699292recruiting International Prospective Registry on Local Treatment Approaches in MLS · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02357810Phase 2 · completed Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074318Phase 1/Phase 2 · terminated Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02821507Phase 2 · completed Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116800Phase 2 · withdrawn Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02247544Phase 2 · completed Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01913652Phase 2 · completed Ph II Cabazitaxel DD Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906876Phase 2 · withdrawn A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01876043Phase 2 · terminated Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343172Phase 1 · completed Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03880123Phase 1 · withdrawn Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03303885completed The FGF/FGFR Signalling Pathway: · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03900078NA · completed Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01692496Phase 2 · completed Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609984Phase 2 · terminated Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03397186Phase 2 · withdrawn Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01957709early Phase 1 · terminated Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816475Phase 2 · unknown Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03773510Phase 3 · withdrawn Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Childhood Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02294084Phase 4 · completed Sitagliptin and Brown Adipose Tissue · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Lipomatous Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983539unknown Detection of Circulating Tumor Cells in Patients With Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Pleomorphic Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659360Phase 2 · completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01653028Phase 2 · completed Alisertib in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01209598Phase 2 · completed PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096912Phase 2 · unknown A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02753361NA · completed Ultra-sounded Guided Regional Blockade for Lipoma Excision · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112463Phase 2 · completed Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00356031Phase 2 · completed Bevacizumab and Radiation Therapy for Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01537744Phase 1 · completed A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma · condition mapped PROBABILISTIC · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02249052Phase 2 · completed Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506596Phase 2 · completed Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02571829Phase 2 · unknown A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01613313Phase 2 · completed A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720174Phase 1 · completed Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567046completed Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Childhood Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059850Phase 1 · withdrawn NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma · condition mapped ALIAS · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00608842Phase 2 · completed Phase 2 Study for the Treatment of Superficial Lipomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00624416Phase 1/Phase 2 · completed Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00422188Phase 1 · completed Deoxycholic Acid Injection for the Treatment of Superficial Lipomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Lipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02587169Phase 1/Phase 2 · unknown Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Retroperitoneal Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00969917Phase 2 · withdrawn Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00233948Phase 1/Phase 2 · terminated Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093080Phase 2 · completed Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01426633Phase 1 · completed Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01477021Phase 1 · completed Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Adult Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060944Phase 2 · completed A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132704completed An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00579501Phase 2 · completed Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792766Phase 1/Phase 2 · completed Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Angiolipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400569Phase 2 · completed Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00633165Phase 2 · unknown Brostallicin Clinical Trial for Myxoid Liposarcoma · condition mapped ONTOLOGY_EXACT · 155 trials mapped (61 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |